Literature DB >> 12861051

Expression of cyclin-dependent kinase 6, but not cyclin-dependent kinase 4, alters morphology of cultured mouse astrocytes.

Karen K Ericson1, David Krull, Peter Slomiany, Martha J Grossel.   

Abstract

Disruption of the pRb pathway is a common mechanism in tumor formation. The D-cyclin-associated kinases, cyclin-dependent kinase (cdk) 4 and cdk6, are important regulators of the G(1)-S phase transition and are elevated in several types of cancers, including gliomas. To investigate potential functional differences in these kinases, mouse astrocytes were taken from chimeric mice and propagated in tissue culture. These multipolar tissue-culture astrocytes were infected with viruses expressing either cdk4 or cdk6. Interestingly, expression of cdk6 resulted in a distinct and rapid morphology change from multipolar to bipolar. This change was not observed in control astrocytes or in astroyctes infected with cdk4. Several other differences in cdk4- and cdk6-infected cells were noted, including differential binding to a subset of cell-cycle inhibitor proteins and a distinct pattern of subcellular localization of these kinases. Immunoblot and immunofluorescence analyses revealed that cdk6-infected astrocytes had an altered expression profile of known markers of glial differentiation. Together, these data indicate several important differences between cdk4 and cdk6 that highlight unique functional roles for these cyclin-dependent kinases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12861051

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  23 in total

Review 1.  Targeting CDK6 in cancer: State of the art and new insights.

Authors:  Solomon Tadesse; Mingfeng Yu; Malika Kumarasiri; Bich Thuy Le; Shudong Wang
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 2.  G1 to S phase cell cycle transition in somatic and embryonic stem cells.

Authors:  Irina Neganova; Majlinda Lako
Journal:  J Anat       Date:  2008-07       Impact factor: 2.610

3.  Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.

Authors:  Michael Woods; Rima Pant; Sanjay M Mallya
Journal:  Int J Oncol       Date:  2010-12       Impact factor: 5.650

4.  Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis.

Authors:  Xian Wang; Christopher Sistrunk; Marcelo L Rodriguez-Puebla
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

Review 5.  A New Way to Treat Brain Tumors: Targeting Proteins Coded by Microcephaly Genes?: Brain tumors and microcephaly arise from opposing derangements regulating progenitor growth. Drivers of microcephaly could be attractive brain tumor targets.

Authors:  Patrick Y Lang; Timothy R Gershon
Journal:  Bioessays       Date:  2018-03-26       Impact factor: 4.345

6.  Transforming activity of Fbxo7 is mediated specifically through regulation of cyclin D/cdk6.

Authors:  Heike Laman; Juan M Funes; Hongtao Ye; Stephen Henderson; Laura Galinanes-Garcia; Eiji Hara; Phillip Knowles; Neil McDonald; Chris Boshoff
Journal:  EMBO J       Date:  2005-08-11       Impact factor: 11.598

7.  Expression of cdk6 in head and neck squamous cell carcinoma.

Authors:  Sopee Poomsawat; Sirima Sanguansin; Jirapa Punyasingh; Paisarn Vejchapipat; Phaibul Punyarit
Journal:  Clin Oral Investig       Date:  2015-05-01       Impact factor: 3.573

8.  Distinct subcellular distribution of cyclin dependent kinase 6.

Authors:  Dawn M Kohrt; Jennifer I Crary; Vasilena Gocheva; Philip W Hinds; Martha J Grossel
Journal:  Cell Cycle       Date:  2009-09-14       Impact factor: 4.534

9.  Forced expression of cyclin-dependent kinase 6 confers resistance of pro-B acute lymphocytic leukemia to Gleevec treatment.

Authors:  Tracy C Kuo; Joseph E Chavarria-Smith; Dan Huang; Mark S Schlissel
Journal:  Mol Cell Biol       Date:  2011-05-02       Impact factor: 4.272

10.  Inhibition of S-adenosylhomocysteine hydrolase decreases cell mobility and cell proliferation through cell cycle arrest.

Authors:  Sae Jeong Park; Hyun Kyung Kong; Ye Sol Kim; Yeon Seon Lee; Jong Hoon Park
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.